Skip to content
10-Q

Quarterly Report

ENDONOVO THERAPEUTICS, INC. ENDV

0001493152-23-029706

← back to feed
Filed
Aug 21, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 21, 2023 317.9M sh
Shares Diluted Q2 2023 · Jun 30, 2023 1.35B sh
Shares Diluted Q2 2023 · Jun 30, 2023 1.34B sh
Shares Diluted Q2 2023 · Jun 30, 2022 134.36M sh
Shares Diluted Q2 2023 · Jun 30, 2022 106.7M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$339K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$329.44K
Long Term Debt Q2 2023 · Jun 30, 2023 $7.05M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $32.6K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $98
Stockholders Equity Q2 2023 · Jun 30, 2023 −$22.2M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$24.37M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$32.18M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$19.16M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$18.04M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$15.77M
Current Liabilities Q2 2023 · Jun 30, 2023 $23.14M
Current Liabilities Q2 2023 · Dec 31, 2022 $33.38M
Total Liabilities Q2 2023 · Jun 30, 2023 $23.22M
Total Liabilities Q2 2023 · Dec 31, 2022 $33.46M
Current Assets Q2 2023 · Jun 30, 2023 $72.83K
Current Assets Q2 2023 · Dec 31, 2022 $15.82K
Total Assets Q2 2023 · Jun 30, 2023 $1.01M
Total Assets Q2 2023 · Dec 31, 2022 $1.28M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.01
Eps Diluted Q2 2023 · Jun 30, 2023 $0.00
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.02
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.05
Eps Basic Q2 2023 · Jun 30, 2023 $0.00
Eps Basic Q2 2023 · Jun 30, 2023 $0.04
Eps Basic Q2 2023 · Jun 30, 2022 −$0.02
Eps Basic Q2 2023 · Jun 30, 2022 −$0.05
Net Income Q2 2023 · Jun 30, 2023 $2.06M
Net Income Q2 2023 · Jun 30, 2023 $9.29M
Net Income Q2 2023 · Mar 31, 2023 $7.23M
Net Income Q2 2023 · Jun 30, 2022 −$2.53M
Net Income Q2 2023 · Jun 30, 2022 −$4.94M
Net Income restated Q2 2023 · Mar 31, 2022 −$2.41M
Operating Income Q2 2023 · Jun 30, 2023 −$1.13M
Operating Income Q2 2023 · Jun 30, 2023 −$1.66M
Operating Income Q2 2023 · Jun 30, 2022 −$1.8M
Operating Income Q2 2023 · Jun 30, 2022 −$2.28M
Gross Profit Q2 2023 · Jun 30, 2023 $45.2K
Gross Profit Q2 2023 · Jun 30, 2023 $128.74K
Gross Profit Q2 2023 · Jun 30, 2022 $267
Gross Profit Q2 2023 · Jun 30, 2022 $1.84K
Cost Of Revenue Q2 2023 · Jun 30, 2023 $4K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $383
Cost Of Revenue Q2 2023 · Jun 30, 2022 $1.1K
Revenue Q2 2023 · Jun 30, 2023 $45.2K
Revenue Q2 2023 · Jun 30, 2023 $132.74K
Revenue Q2 2023 · Jun 30, 2022 $650
Revenue Q2 2023 · Jun 30, 2022 $2.93K